We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.93% | 2.14 | 2.10 | 2.18 | 2.19 | 2.11 | 2.11 | 1,367,460 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.92 | 7.3M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/11/2018 16:18 | Can't even buy 2000 shares now.....no market makers want to take stock check the rsp | kirk 6 | |
16/11/2018 16:11 | L2 showing near evenly matched total quantities for each the bid and ask. Remains being steadily bought and moving higher. f | fillipe | |
16/11/2018 16:07 | Boom where are the regulars regurgitators 1retirement and never wrong Bitcoin looool | kirk 6 | |
16/11/2018 16:06 | IF this is a pumpIts a big one and will probably go a fair bit higher | kop202 | |
16/11/2018 16:02 | 200k for 25p showing at almost the highest ask. f | fillipe | |
16/11/2018 16:01 | Don't miss the next big rise over at Evgen Pharma: | aoifesweb | |
16/11/2018 15:59 | Likely to see further upside here, imo. f | fillipe | |
16/11/2018 15:58 | OK KirkYou can take off your incontinence pad now | kop202 | |
16/11/2018 15:57 | Iceberg orders galore | kop202 | |
16/11/2018 15:55 | He he in the money well and truly | knowing | |
16/11/2018 15:53 | Showing 17p v 17.45p and being well wanted. f | fillipe | |
16/11/2018 15:52 | L2 - a lot being bought @ 17p and above, as I type. f | fillipe | |
16/11/2018 15:50 | 1p away from a profit after all that.... should be there Monday haha | kirk 6 | |
16/11/2018 14:27 | At AGM the company set out a time lime from memory: Early august, further results from PII trial note this was followed a few weeks later with confirmation of the strategic partnership re: MAP Mid November / early December, full analyses of PIII trial Key issues are of course explanations for non responders with positive DS DNA on active in a) the Europe cohort and b) US cohort If the data analyses can point towards plausible explanations then IMM will be interesting. The board's scientists will be data led and by doubling down on Lupuzor and setting aside the rest of the pipeline, they are signalling Lupuzor is indeed interesting. | youngharry2 | |
16/11/2018 13:30 | IF news breaks the easy money will be made for those that are in nowAfter news ...well don't bank on getting ahead as it is then that a retrace will happenLimited downside at the moment...but waiting for the 20p seems reasonable30% more but hey it's probably a pump anyway | kop202 | |
16/11/2018 13:12 | I agree with others, this needs to be materially through 20p before the "herd" arrive and things begin to look more intriguing,....DYOR, will hold on for next week see what it holds | qs99 | |
16/11/2018 13:04 | Good for a punt that's right | bmnsa | |
16/11/2018 12:51 | thanks NYB....an interesting rise over last few days... | qs99 | |
16/11/2018 12:49 | NYAccording to Bloomberg average 30d volume is 540kLook at the volumes over the last few daysWhat do you reckon? | kop202 | |
16/11/2018 12:45 | indeed nice 50% gain for those who pumped from 10p I suppose | mister md | |
16/11/2018 12:37 | Level 2. Nothing much going on at present ...1 v 1 | ny boy | |
16/11/2018 12:36 | Needs to stay above 19/20p to become more interesting, the punters will take this to 17p and sell off. There is no indication of serious news as volumes are low, still good for a quickie trade, if that’s your thing. | ny boy | |
16/11/2018 12:19 | Ok, well it does seem to be gathering a head of steam. Let's see. Very very speculative IMO | qs99 | |
16/11/2018 12:18 | It would be all too ironic if AstraZeneca is accumulating shares. After all isn’t Nobby an alumnist of this company who also happens to be the biggest basher of the stock on the entire BB. It would just be all too fitting and enjoyable to witness | lerichman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions